Mark Morrow
Impact in
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research
- Microtubule and mitosis dynamics
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
-
- Cancer, Lipids, and Metabolism 2
- Protease and Inhibitor Mechanisms 1
- Co-authors
- S. Gail Eckhardt (6 shared papers)Daniel L. Gustafson (5 shared papers)Todd M. Pitts (3 shared papers)Lia Gore (6 shared papers)Cindy L. O’Bryant (6 shared papers)M. Basche (4 shared papers)Scott N. Holden (3 shared papers)Sabine Eckhardt (4 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Annals of Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Leukemia (1 paper)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Mark Morrow
13 papers receiving 651 citations
Peers
Comparison fields: 5 of 55
- Immunology and Allergy 39
- Cell Biology 95
- Cancer Research 91
- Oncology 102
- Molecular Biology 235
Countries citing papers authored by Mark Morrow
This map shows the geographic impact of Mark Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Morrow more than expected).
Fields of papers citing papers by Mark Morrow
This network shows the impact of papers produced by Mark Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Morrow. The network helps show where Mark Morrow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Morrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 109 | |
| 2 | 2006 | 104 | |
| 3 | 2006 | 84 | |
| 4 | 2000 | 78 | |
| 5 | 2009 | 64 | |
| 6 | 2010 | 61 | |
| 7 | 2006 | 38 | |
| 8 | 2007 | 34 | |
| 9 | 2007 | 32 | |
| 10 | 2007 | 22 | |
| 11 | 2008 | 21 | |
| 12 | 2006 | 14 | |
| 13 | 2008 | 10 |
About Mark Morrow
Mark Morrow is a scholar working on Oncology, Cancer Research, Cell Biology, Molecular Biology and Immunology and Allergy, having authored 13 papers that have together received 671 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer therapeutics and mechanisms (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Immunology and Allergy (39 citations), Cell Biology (95 citations), Cancer Research (91 citations), Oncology (102 citations) and Molecular Biology (235 citations). Mark Morrow has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include S. Gail Eckhardt, Daniel L. Gustafson, Todd M. Pitts, Lia Gore, Cindy L. O’Bryant, M. Basche, Scott N. Holden, Sabine Eckhardt, John J. Tentler and S. Gail Eckhardt. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.